Dzeshka MS, Shantsila A, Shantsila E, Lip GYH. Atrial fibrillation and hypertension. Hypertension. 2017;70:854–61.

Article  CAS  Google Scholar 

Harskamp RE, Lucassen WAM, Lopes RD, Himmelreich JCL, Parati G, Weert H. Risk of stroke and bleeding in relation to hypertension in anticoagulated patients with atrial fibrillation: a meta-analysis of randomised controlled trials. Acta Cardiol. 2022;77:191–5.

Article  CAS  Google Scholar 

Vasan RS, Larson MG, Leip EP, Evans JC, O’Donnell CJ, Kannel WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N. Engl J Med. 2001;345:1291–7.

Article  CAS  Google Scholar 

Carey RM, Muntner P, Bosworth HB, Whelton PK. Prevention and control of hypertension: JACC Health Promotion Series. J Am Coll Cardiol. 2018;72:1278–93.

Article  Google Scholar 

Kim D, Yang P-S, Kim T-H, Jang E, Shin H, Kim HY, et al. Ideal blood pressure in patients with atrial fibrillation. J Am Coll Cardiol. 2018;72:1233–45.

Article  Google Scholar 

Schutte AE, Kollias A, Stergiou GS. Blood pressure and its variability: classic and novel measurement techniques. Nat Rev Cardiol. 2022;19:643–54.

Article  Google Scholar 

Lee SR, Choi YJ, Choi EK, Han KD, Lee E, Cha MJ, et al. Blood pressure variability and incidence of new-onset atrial fibrillation: a nationwide population-based study. Hypertension. 2020;75:309–15.

Article  CAS  Google Scholar 

Proietti M, Romiti GF, Olshansky B, Lip GYH. Systolic blood pressure visit-to-visit variability and major adverse outcomes in atrial fibrillation: The AFFIRM Study (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). Hypertension. 2017;70:949–58.

Article  CAS  Google Scholar 

Chiang C-E, Chao T-F, Choi E-K, Lim TW, Krittayaphong R, Li M. et al. Stroke Prevention in Atrial Fibrillation. JACC: Asia. 2022;2:395–411.

Google Scholar 

Gorog DA, Gue YX, Chao T-F, Fauchier L, Ferreiro JL, Huber K, et al. Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: executive summary of a European and Asia-Pacific Expert Consensus Paper. Thromb Haemost. 2022;122:1625–52.

Article  Google Scholar 

Kim HK, Tantry US, Smith SC Jr, Jeong MH, Park SJ, Kim MH, et al. The East Asian Paradox: An updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease. Thromb Haemost. 2021;121:422–32.

Article  Google Scholar 

Pagonas N, Schmidt S, Eysel J, Compton F, Hoffmann C, Seibert F, et al. Impact of atrial fibrillation on the accuracy of oscillometric blood pressure monitoring. Hypertension. 2013;62:579–84.

Article  CAS  Google Scholar 

Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3:692–4.

Article  CAS  Google Scholar 

Rosendaal FR, Cannegieter SC, van der Meer FJ, Briët E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69:236–9.

Article  CAS  Google Scholar 

Lip GYH, Frison L, Grind M. Effect of hypertension on anticoagulated patients with atrial fibrillation. Eur Heart J. 2007;28:752–9.

Article  CAS  Google Scholar 

Rao MP, Halvorsen S, Wojdyla D, Thomas L, Alexander JH, Hylek EM, et al. Blood pressure control and risk of stroke or systemic embolism in patients with atrial fibrillation: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial. J Am Heart Assoc. 2015;4:e002015.

Article  Google Scholar 

Nagarakanti R, Wallentin L, Noack H, Brueckmann M, Reilly P, Clemens A, et al. Comparison of characteristics and outcomes of dabigatran versus warfarin in hypertensive patients with atrial fibrillation (from the RE-LY Trial). Am J Cardiol. 2015;116:1204–9.

Article  CAS  Google Scholar 

Lip GYH, Lane DA, Lenarczyk R, Boriani G, Doehner W, Benjamin LA, et al. Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke. Eur Heart J. 2022;43:2442–60.

Article  CAS  Google Scholar 

Rosei EA, Chiarini G, Rizzoni D. How important is blood pressure variability? Eur Heart J Suppl. 2020;22:E1–e6.

Article  Google Scholar 

Parati G, Torlasco C, Pengo M, Bilo G, Ochoa JE. Blood pressure variability: its relevance for cardiovascular homeostasis and cardiovascular diseases. Hypertens Res. 2020;43:609–20.

Article  Google Scholar 

Kronish IM, Lynch AI, Oparil S, Whittle J, Davis BR, Simpson LM, et al. The association between antihypertensive medication nonadherence and visit-to-visit variability of blood pressure. Hypertension. 2016;68:39–45.

Article  CAS  Google Scholar 

Kodani E, Inoue H, Atarashi H, Okumura K, Yamashita T, Otsuka T, et al. Impact of blood pressure visit‐to‐visit variability on adverse events in patients with nonvalvular atrial fibrillation: subanalysis of the J‐RHYTHM Registry. J Am Heart Assoc. 2021;10:e018585.

Article  Google Scholar 

Haring B, Hunt RP, Manson JE, LaMonte MJ, Klein L, Allison MA, et al. Blood pressure variability and heart failure hospitalization: results from the women’s health initiative. Am J Preventive Med. 2022;63:410–8.

Article  Google Scholar 

Ernst ME, Chowdhury EK, Beilin LJ, Margolis KL, Nelson MR, Wolfe R, et al. Long-term blood pressure variability and risk of cardiovascular disease events among community-dwelling elderly. Hypertension. 2020;76:1945–52.

Article  CAS  Google Scholar 

Nuyujukian DS, Koska J, Bahn G, Reaven PD, Zhou JJ. Blood pressure variability and risk of heart failure in ACCORD and the VADT. Diabetes Care. 2020;43:1471–8.

Article  CAS  Google Scholar 

Mehlum MH, Liestøl K, Kjeldsen SE, Julius S, Hua TA, Rothwell PM, et al. Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks. Eur Heart J. 2018;39:2243–51.

Article  CAS  Google Scholar 

Wei F-F, Zhou Y, Thijs L, Xue R, Dong B, He X, et al. Visit-to-visit blood pressure variability and clinical outcomes in patients with heart failure with preserved ejection fraction. Hypertension. 2021;77:1549–58.

Article  CAS  Google Scholar 

Anter E, Jessup M, Callans DJ. Atrial fibrillation and heart failure. Circulation. 2009;119:2516–25.

Article  Google Scholar 

Carlisle MA, Fudim M, DeVore AD, Piccini JP. Heart failure and atrial fibrillation, like fire and fury. JACC Heart Fail. 2019;7:447–56.

Article  Google Scholar 

Lorell BH, Carabello BA. Left ventricular hypertrophy. Circulation. 2000;102:470–9.

Article  CAS  Google Scholar 

Oh GC, Cho H-J. Blood pressure and heart failure. Clin Hypertens. 2020;26:1.

Article  Google Scholar 

Arbelo E, Aktaa S, Bollmann A, D’Avila A, Drossart I, Dwight J, et al. Quality indicators for the care and outcomes of adults with atrial fibrillation. Europace. 2021;23:494–5.

Article  Google Scholar 

Krittayaphong R, Chantrarat T, Rojjarekampai R, Jittham P, Sairat P, Lip GYH. Poor time in therapeutic range control is associated with adverse clinical outcomes in patients with non-valvular atrial fibrillation: a report from the nationwide COOL-AF Registry. J Clin Med. 2020;9:1698.

Article  Google Scholar 

Krittayaphong R, Winijkul A, Pirapatdit A, Chiewvit P, Komoltri C, Boonyapisit W, et al. SAMe-TT2R2 score for prediction of suboptimal time in therapeutic range in a Thai population with atrial fibrillation. Singap Med J. 2020;61:641–6.

Article  CAS  Google Scholar 

Group JCSJW. Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013). Circ J. 2014;78:1997–2021.

Chao TF, Joung B, Takahashi Y, Lim TW, Choi EK, Chan YH, et al. 2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary. Thromb Haemost. 2022;122:20–47.

Article  Google Scholar 

Liu T, Hui J, Hou YY, Zou Y, Jiang WP, Yang XJ, et al. Meta-analysis of efficacy and safety of low-intensity warfarin therapy for East Asian patients with nonvalvular atrial fibrillation. Am J Cardiol. 2017;120:1562–7.

Article  CAS  Google Scholar 

Cho JG, Lee KH, Kim YR, Kim S, Gwak J, Cho E, et al. Standard-intensity versus low-intensity anticoagulation with warfarin in asian patients with atrial fibrillation: a multi-center, randomized controlled trial. Clin Appl Thromb Hemost. 2023;29:10760296231171081.

Article  CAS  Google Scholar 

Lip GYH. The ABC pathway: an integrated approach to improve AF management. Nat Rev Cardiol. 2017;14:627–8.

Article  Google Scholar 

Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2020;42:373–498.

Article  Google Scholar 

Lim HM, Chia YC, Ching SM, Chinna K. Number of blood pressure measurements needed to estimate long-term visit-to-visit systolic blood pressure variability for predicting cardiovascular risk: a 10-year retrospective cohort study in a primary care clinic in Malaysia. BMJ Open. 2019;9:e025322.

Article  Google Scholar 

Li YG, Lee SR, Choi EK, Lip GY. Stroke prevention in atrial fibrillation: focus on Asian patients. Korean Circ J. 2018;48:665–84.

Article  CAS  Google Scholar